cas 262860-10-6|| where to buy rel-Methyl (3aR,8aR)-3,3a,8,8a-tetrahydro-5-methoxy-3a,8-dimethylpyrrolo[2,3-b]indole-1(2H)-carboxylate

Nombre del producto:rel-Methyl (3aR,8aR)-3,3a,8,8a-tetrahydro-5-methoxy-3a,8-dimethylpyrrolo[2,3-b]indole-1(2H)-carboxylate

IUPAC Name:methyl (3aS,8aS)-5-methoxy-3a,8-dimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indole-1-carboxylate

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 262860-10-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :262860-10-6; Fórmula molecular:C15H20N2O3; Punto de fusión:-; Código de sonrisas:C[C@]12[C@](N(C(OC)=O)CC1)(N(C)C=3C2=CC(OC)=CC3)[H]; Densidad:

: Número de catálogo:CM1075214; Peso molecular:276.34; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Buntanetap; Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide. As the world ages, the demand for Alzheimer's disease (AD) drugs increases dramatically. Alzheimer's disease (AD) will also continue to be an industry focus in 2024. There are various types of AD drugs, including vaccines, monoclonal antibodies, and small molecule inhibitors. Lecanemab has become the first new AD treatment to be fully approved by the FDA in 20 years. Lilly's AD treatment donanemab is under review by the FDA. Among small molecule drugs, buntanetap is a a novel translational inhibitor developed by Annovis. Buntanetap reduces levels of multiple neurotoxic proteins (beta amyloid, tau, alpha synuclein, and TDP43), thereby improving synaptic transmission and axonal transport and reducing inflammation, which has been shown to be a cause of cell death reason. By attacking multiple pathways associated with neurodegeneration, buntanetap can reverse Alzheimer's disease's devastating effects on thinking and memory.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.